ReviewCancers2026

Selected Blood-Accessible Biomarkers in Prostate Cancer Radiotherapy: A PRISMA-ScR Timing-Window Framework Beyond PSA.

Miloš Grujić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.